Qnasl Aerosol, Metered
Product Images NDC 59310-406

42 FDA label images from Teva Respiratory, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 42 technical images submitted to the FDA as part of the official labeling for Qnasl (NDC 59310-406). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Respiratory, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure. (Image 1)

Chemical Structure. (Image 1)
Chemical structure of beclomethasone dipropionate, the active ingredient in QNASL nasal aerosol. The diagram displays the steroid backbone with characteristic rings and attached functional groups.*
FDA Label Image

Figure H 80 (Image 10)

Figure H 80 (Image 10)
Illustration showing a hand operating a blue nasal aerosol inhaler device. The inhaler has a counter display and is labeled with usage instructions on the attached leaflet, demonstrating how to hold and use the device, identified as part of the QNASL (Beclomethasone dipropionate) metered nasal aerosol system by Teva Respiratory, LLC.*
FDA Label Image

Teva Logo (Image 11)

FDA Label Image

Figure A (Image 12)

Figure A (Image 12)
An instructional diagram of the QNASL nasal aerosol device showing labeled parts: canister, protective dust cap, and nasal actuator tip. The canister includes an insert label with product name Qnasl 40 mcg nasal aerosol, indicating the medicine is beclomethasone dipropionate at 40 mcg per spray.*
FDA Label Image

Figure B (Image 13)

Figure B (Image 13)
An instructional diagram labeled Figure B showing a hand holding a QNASL nasal aerosol device. The device displays a spray counter with the number 60 visible, highlighting the method of use and spray counting for QNASL nasal aerosol containing beclomethasone dipropionate.*
FDA Label Image

Figure C (Image 14)

Figure C (Image 14)
Illustration showing a woman using a nasal aerosol inhaler, holding it near her nose with her thumb pressing the canister, demonstrating proper positioning for nasal administration of the medication.*
FDA Label Image

Figure D (Image 15)

Figure D (Image 15)
An instructional illustration showing a young girl using a nasal aerosol inhaler. She holds the inhaler with one hand near her nose while using her other hand to gently press on one nostril, demonstrating proper nasal inhalation technique likely related to QNASL (Beclomethasone dipropionate) nasal aerosol use.*
FDA Label Image

Figure E (Image 16)

Figure E (Image 16)
An instructional illustration labeled FIGURE E showing a woman holding a metered nasal aerosol spray near her nose. She uses her finger to close one nostril, preparing to administer the nasal spray into the open nostril, demonstrating the proper technique for nasal spray use.*
FDA Label Image

Figure F 40 (Image 17)

Figure F 40 (Image 17)
Illustration labeled Figure F showing a hand holding a QNASL metered nasal aerosol administering device being wiped or cleaned with a cloth or tissue. The image focuses on the nozzle area of the blue and white inhaler device.*
FDA Label Image

Figure G 40 (Image 18)

Figure G 40 (Image 18)
An instructional illustration labeled 'FIGURE G' showing a nasal spray device with liquid spray exiting the nozzle. A red 'X' overlays the image, indicating a prohibition or warning against the action depicted, likely instructing not to spray in a certain way or direction.*
FDA Label Image

Figure H 40 (Image 19)

Figure H 40 (Image 19)
An instructional diagram labeled 'FIGURE H' showing a hand holding a QNASL metered dose nasal aerosol inhaler. The illustration focuses on gripping the blue and white device, indicating how to hold it properly during use.*
FDA Label Image

Teva Logo (Image 2)

FDA Label Image

Teva Logo (Image 20)

FDA Label Image

Figure A (Image 21)

Figure A (Image 21)
An instructional diagram labeled 'FIGURE A' depicting parts of the QNASL nasal aerosol device. The diagram identifies the canister containing the medication, a removable protective dust cap, and the nasal actuator tip used for administration. The canister label shows Beclomethasone dipropionate 80 mcg per spray.*
FDA Label Image

Figure B (Image 22)

Figure B (Image 22)
An instructional diagram illustrating the correct positioning of a QNASL (beclomethasone dipropionate) 80 mcg per spray nasal aerosol. The image highlights the spray counter display on the nasal aerosol device being held by a hand, indicating the number of sprays remaining. The product is shown in use, focusing on the spray counter feature.*
FDA Label Image

Figure C (Image 23)

Figure C (Image 23)
An instructional illustration showing a person holding a QNASL nasal aerosol device near their nose, demonstrating how to position the device for nasal administration. The image focuses on correct placement of the metered aerosol spray for nasal use.*
FDA Label Image

Figure D (Image 24)

Figure D (Image 24)
An instructional illustration labeled 'FIGURE D' showing a person using a blue QNASL aerosol metered nasal spray. The person is holding the nasal spray near their nostril and appears to be preparing for administration, consistent with directions for use of a nasal aerosol spray product.*
FDA Label Image

Figure E (Image 25)

Figure E (Image 25)
Instructional diagram showing a person holding a QNASL nasal aerosol metered spray near the nose, with an arrow indicating the position or action involved, likely demonstrating how to use the nasal spray properly. The person’s finger is positioned near the nostril, highlighting nasal administration.*
FDA Label Image

Figure F 80 (Image 26)

Figure F 80 (Image 26)
Instructional illustration showing a hand holding a blue nasal aerosol device labeled '811' and cleaning its nozzle with a tissue or cloth. This figure demonstrates how to properly clean the nasal spray tip.*
FDA Label Image

Figure G 80 (Image 27)

Figure G 80 (Image 27)
Illustration labeled 'Figure G' showing a nasal spray nozzle with a red X over it and spray droplets, indicating an action that should not be performed, likely related to improper usage of the nasal aerosol device.*
FDA Label Image

Figure H 80 (Image 28)

Figure H 80 (Image 28)
An instructional illustration labeled Figure H, showing a hand holding a QNASL metered-dose nasal aerosol inhaler with a blue dose counter indicating '000'. The device includes a white nasal spray nozzle and a partially visible label on the canister.*
FDA Label Image

Logo (Image 29)

FDA Label Image

Figure A (Image 3)

Figure A (Image 3)
An illustration labeled Figure A showing the components of a QNASL nasal aerosol spray. The diagram identifies the canister, protective dust cap, and nasal actuator tip of the metered nasal spray device containing Beclomethasone dipropionate 80 mcg per spray.*
FDA Label Image

Figure A (Image 30)

Figure A (Image 30)
An instructional diagram labeled Figure A showing the components of a QNASL nasal aerosol spray device. The illustration identifies the canister, protective dust cap, and nasal actuator tip as key parts of the device.*
FDA Label Image

Figure B (Image 31)

Figure B (Image 31)
Illustration showing a hand holding a QNASL nasal aerosol inhaler with the spray counter visible on the device. The spray counter displays the number 60, indicating the remaining sprays. The device is labeled for children's QNASL 40 mcg per spray dosage.*
FDA Label Image

Figure C (Image 32)

Figure C (Image 32)
An instructional illustration showing a person holding a QNASL nasal aerosol inhaler near their nose, demonstrating the proper placement for nasal administration of the medication.*
FDA Label Image

Figure D (Image 33)

Figure D (Image 33)
An instructional illustration showing a person holding a nasal aerosol inhaler close to their nostril with one hand, while using the other hand to gently press the opposite nostril closed. This demonstrates the proper technique for using the QNASL nasal aerosol metered spray.*
FDA Label Image

Figure E (Image 34)

Figure E (Image 34)
An instructional illustration showing a person holding a QNASL nasal aerosol inhaler close to their nose with one hand while using a finger on the other hand to hold the opposite nostril closed, demonstrating the correct administration technique for the nasal spray.*
FDA Label Image

Figure F 40 (Image 35)

Figure F 40 (Image 35)
An instructional illustration labeled Figure F shows hands using a blue metered-dose nasal aerosol device (QNASL) with a white tip, held along with a tissue, demonstrating its use or cleaning method.*
FDA Label Image

Figure G 40 (Image 36)

Figure G 40 (Image 36)
Illustration labeled 'FIGURE G' showing a nasal spray nozzle dispensing liquid with a red 'X' over it, indicating the action of spraying liquid downwards is incorrect or should be avoided.*
FDA Label Image

Figure H 40 (Image 37)

Figure H 40 (Image 37)
Illustration showing a hand holding a QNASL nasal aerosol device with a blue actuator and a white mouthpiece cover. A label with partial text is visible on the canister behind the actuator. The image is labeled "FIGURE H."*
FDA Label Image

Logo (Image 38)

FDA Label Image

80 Mcg Carton (Image 39)

80 Mcg Carton (Image 39)
Qnasl (beclomethasone dipropionate) 80 mcg per spray nasal aerosol packaging label. The carton contains 120 metered sprays with 10.6 g net contents. It includes usage information such as no priming required, for intranasal use with Qnasl actuator only, recommended dosage of two sprays in each nostril once a day, and storage instructions. The labeler is Teva Respiratory, LLC.*
FDA Label Image

Figure B (Image 4)

Figure B (Image 4)
An instructional illustration showing QNASL nasal aerosol held between the thumb and forefinger. The blue and white device features a spray counter displaying the number 120. The label on the aerosol indicates beclomethasone dipropionate 80 mcg per spray. The illustration includes a label pointing to the spray counter.*
FDA Label Image

40 Mcg Carton (Image 40)

40 Mcg Carton (Image 40)
Packaging label for Children's Qnasl 40 mcg Nasal Aerosol containing beclomethasone dipropionate. The aerosol delivers 40 mcg per spray and is intended for nasal administration. The label indicates 60 metered sprays and net content of 6.8 g. It is manufactured by Teva Respiratory, LLC and requires use with the Qnasl actuator. The label mentions no priming is required and includes storage and usage instructions.*
FDA Label Image

40 Mcg Sample Carton (Image 41)

40 Mcg Sample Carton (Image 41)
Children's Qnasl 40 mcg (beclomethasone dipropionate) Nasal Aerosol 40 mcg per spray packaging label. The label indicates the product is for intranasal use with Qnasl actuators only, contains 60 metered sprays, and weighs 6.8 g net. Manufactured by Teva Respiratory, LLC, it includes storage instructions, warnings, and usage details. The label also notes no priming is required and this is a professional sample not for sale or reimbursement.*
FDA Label Image

80 Mcg Sample Carton (Image 42)

80 Mcg Sample Carton (Image 42)
Packaging label for Qnasl (beclomethasone dipropionate) Nasal Aerosol 80 mcg per spray, a metered nasal aerosol produced by Teva Respiratory, LLC. The label indicates this is a professional sample, not for sale or reimbursement, with 50 metered sprays and net contents of 6.8 g. Instructions mention no priming required and intranasal use with Qnasl actuator only.*
FDA Label Image

Figure C (Image 5)

Figure C (Image 5)
An instructional illustration showing a person holding a QNASL metered-dose nasal aerosol close to their nose in preparation for administration. The image focuses on correct positioning of the device for nasal use.*
FDA Label Image

Figure D (Image 6)

Figure D (Image 6)
An instructional illustration labeled 'FIGURE D' showing a person holding a QNASL nasal aerosol inhaler near their nose with one finger placed on the other nostril, demonstrating preparation or administration technique for the nasal spray.*
FDA Label Image

Figure E (Image 7)

Figure E (Image 7)
Instructional illustration showing a person holding a QNASL (beclomethasone dipropionate) nasal aerosol inhaler near their nose, with a blue arrow indicating to press the top of the inhaler. The person is using their other hand to close the opposite nostril, demonstrating how to properly use the nasal spray.*
FDA Label Image

Figure F 80 (Image 8)

Figure F 80 (Image 8)
An instructional illustration labeled Figure F showing hands holding a blue nasal aerosol inhaler. The image depicts a step involving a cloth or tissue being used to clean or wipe the nozzle of the inhaler device, emphasizing device maintenance or hygiene.*
FDA Label Image

Figure G 80 (Image 9)

Figure G 80 (Image 9)
An instructional illustration labeled 'FIGURE G' showing a metered-dose inhaler releasing aerosol particles downward with a large red cross over it, indicating that this action is not recommended.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.